An association of private clinics in Brazil has begun negotiations to purchase 5 million doses of a potential coronavirus vaccine developed by Indian lab Bharat Biotech. However, the so-called Covaxin has faced severe criticism from that country’s scientific community, as researchers claim efficiency studies have not been sufficiently transparent.
In Brazil, many experts have criticized the move by private clinics for another reason, as it would be a way to allow higher-income people to “cut in line” and receive vaccines before needier populations. This is especially problematic considering the federal government has been nonchalant about its own vaccination plans — with President Jair Bolsonaro being an active misinformation agent about the safety of Covid-19 vaccines.
Support this coverage →President Luiz Inácio Lula da Silva issued a provisional decree laying the foundations for Eco…
Finance Minister Fernando Haddad on Wednesday delivered to House Speaker Arthur Lira a bill with…
Brazil's IPCA-15 mid-month inflation measurement posted a 0.21 percent increase in April, following the 0.36…
It is not about denying the environmental problems and challenges Brazil faces — that are…
Shareholders of Brazil’s oil giant Petrobras approved in a Thursday general meeting the payment of…
This week, the world celebrates International Earth Day, a yearly call to action to confront…